DRD2 Gene Myoclonic Dystonia DRD2 Related Genetic Test sale cost 4400 AED
POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test sale cost 4400 AED POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
COL6A6 Gene Myopathy COL6A6 Related Genetic Test sale cost 4400 AED COL6A6 Gene Myopathy COL6A6 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DRD2 Gene Myoclonic Dystonia DRD2 Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DRD2 gene myoclonic dystonia DRD2 related genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DRD2 gene, which are linked to the development of myoclonic dystonia. Myoclonic dystonia is a neurological movement disorder characterized by quick, involuntary muscle contractions (myoclonus) and prolonged muscle contractions (dystonia) that result in twisting and repetitive movements or abnormal postures. The DRD2 gene plays a crucial role in the dopamine signaling pathway, which is essential for controlling movement, emotional response, and pain processing in the brain. Mutations in the DRD2 gene can disrupt this pathway, leading to the symptoms associated with myoclonic dystonia.

The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. It involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic alterations in the DRD2 gene that might be responsible for the condition. This test is crucial for individuals experiencing symptoms of myoclonic dystonia or those with a family history of the disorder, as it can provide a definitive diagnosis and guide treatment options.

The cost of the DRD2 gene myoclonic dystonia DRD2 related genetic test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test offers invaluable insights into the genetic basis of the disorder, enabling targeted interventions and potentially improving the quality of life for those affected by myoclonic dystonia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DRD2 Gene Myoclonic Dystonia DRD2 Related Genetic Test

Test Name: DRD2 Gene Myoclonic dystonia DRD2 related Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for DRD2 Gene Myoclonic dystonia, DRD2 related NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with DRD2 Gene Myoclonic dystonia, DRD2 related

Test Details:

The DRD2 gene, also known as the dopamine receptor D2 gene, is associated with a condition called myoclonic dystonia. Myoclonic dystonia is a movement disorder characterized by sudden, brief muscle contractions (myoclonus) and dystonia, which is the sustained muscle contractions causing abnormal postures or repetitive movements.

A DRD2-related NGS genetic test is a genetic test that uses next-generation sequencing (NGS) technology to analyze the DRD2 gene for any genetic variations or mutations that may be associated with myoclonic dystonia. This test can help in diagnosing individuals with myoclonic dystonia and determining the underlying cause of the condition.

NGS technology allows for the simultaneous analysis of multiple genes or the entire genome, providing a comprehensive view of the genetic variations in the DRD2 gene. This can help identify specific mutations or variations that may be responsible for the development of myoclonic dystonia.

Genetic testing for myoclonic dystonia can be useful for individuals with symptoms suggestive of the condition, as it can provide a definitive diagnosis and guide treatment decisions. It can also be beneficial for family members of affected individuals, as it can help identify carriers of the genetic mutation and provide information about the risk of developing the condition.

It is important to note that genetic testing for myoclonic dystonia should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the results.

Test Name DRD2 Gene Myoclonic dystonia DRD2 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DRD2 Gene Myoclonic dystonia, DRD2 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DRD2 Gene Myoclonic dystonia, DRD2 related
Test Details

The DRD2 gene, also known as the dopamine receptor D2 gene, is associated with a condition called myoclonic dystonia. Myoclonic dystonia is a movement disorder characterized by sudden, brief muscle contractions (myoclonus) and dystonia, which is the sustained muscle contractions causing abnormal postures or repetitive movements.

A DRD2-related NGS genetic test is a genetic test that uses next-generation sequencing (NGS) technology to analyze the DRD2 gene for any genetic variations or mutations that may be associated with myoclonic dystonia. This test can help in diagnosing individuals with myoclonic dystonia and determining the underlying cause of the condition.

NGS technology allows for the simultaneous analysis of multiple genes or the entire genome, providing a comprehensive view of the genetic variations in the DRD2 gene. This can help identify specific mutations or variations that may be responsible for the development of myoclonic dystonia.

Genetic testing for myoclonic dystonia can be useful for individuals with symptoms suggestive of the condition, as it can provide a definitive diagnosis and guide treatment decisions. It can also be beneficial for family members of affected individuals, as it can help identify carriers of the genetic mutation and provide information about the risk of developing the condition.

It is important to note that genetic testing for myoclonic dystonia should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the results.

SKU: TEST-1783 Category:

Related products